GnRHa therapy poses no BMD risk for children with CAH
Gonadotropin-releasing hormone agonist therapy in children with congenital adrenal hyperplasia does not compromise bone mineral density, US researchers say.
Gonadotropin-releasing hormone agonist therapy in children with congenital adrenal hyperplasia does not compromise bone mineral density, US researchers say.
Applying a machine learning technique to hormone measurements can help determine whether a girl with early signs of puberty has nonprogressive premature thelarche or may require treatment for idiopathic central precocious puberty, suggest study findings published in The Journal of Clinical Endocrinology & Metabolism.
Adolescents with a history of idiopathic central precocious puberty may be at increased risk of polycystic ovary syndrome, researchers report.

Suicidality or self-harm is a frequent cause of hospital admission among gender variant/diverse young people, report researchers.

Marie Lindhardt Ljubicic discusses recent findings from the COPENHAGEN Minipuberty Study, which shed new light on this developmental stage in baby girls.

More than half of girls with central precocious puberty have abnormal findings on magnetic resonance imaging of the brain, report researchers.
A study of preterm boys shows increased androgen levels at the estimated time of birth in those with low birthweight.
Most young people treated within a paediatric gender identity development service remain committed to pursuing hormonal treatment in line with their perceived gender, research shows.

Most children and adolescents who identify as transgender or gender variant continue with hormone interventions after discharge from youth endocrine services, a study shows.

Researchers report a “biphasic and prolonged” minipuberty in girls, and provide reference ranges for reproductive hormones during the first year of life.